THYRO3 ALPHA PHARMA: Compound Profile
Thymosin Alpha-1 is a synthetic immunomodulatory peptide that has captured significant attention in laboratory research applications. This 28-amino acid compound demonstrates remarkable activity in modulating T-cell mediated immunity pathways within controlled research environments. The Alpha Pharma formulation provides researchers with a standardised research grade preparation suitable for comprehensive in-vitro and preclinical investigations. Scientists at Stroid UK Shop have observed increasing demand for this compound across immunological research protocols examining cellular immune response mechanisms and adaptive immunity modulation.
Laboratory Research Applications
Researchers investigating immunomodulatory compounds frequently study Thymosin Alpha-1 for its documented effects on T-lymphocyte differentiation and maturation processes. The peptide demonstrates significant activity in enhancing dendritic cell function and promoting Th1-type immune responses in animal models. Laboratory studies have examined its role in modulating cytokine production, particularly interferon-gamma and interleukin-2 expression patterns. Research teams studying immune system dysfunction often incorporate this compound alongside other immunomodulatory agents from our metabolic research collection. Comparative studies frequently evaluate this compound against established research tools from our selective androgen receptor modulator range and peptide research compounds to understand immune-metabolic interactions in controlled laboratory settings.
Technical Specifications
| Parameter | Specification |
|---|---|
| CAS Registry | 62304-98-7 |
| Molecular Formula | C₁₂₉H₂₁₅N₃₃O₥₅ |
| Molecular Weight | 3108.44 g/mol |
| Sequence Length | 28 amino acids |
| Storage Temperature | -20°C (lyophilised) |
| Solubility | Water soluble |
| Research Grade | Laboratory standard |
Research Compliance Statement
THYRO3 Alpha Pharma is supplied exclusively for legitimate scientific research purposes and in-vitro laboratory applications. This immunomodulatory peptide is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional guidelines and local regulations governing peptide research compounds. All studies involving this material should be conducted under appropriate laboratory conditions with proper safety protocols.
